Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of pre-treatment with recombinant human TSH on thyroid 131I uptake and goiter reduction in patients with non-toxic multinodular goiter
2005-001078-29Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Oct 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multinodular goiter (MNG) comparing Thyrogen + radioiodine (I-131) with Placebo + radioiodine (I-131) (2 arms). Primary endpoints: Effect on thyroid 131I uptake and Goiter volume reduction. Started Oct 2005; status: completed.
02
Drugs
thyrotropin alfa
03
Conditions
multinodular goiter (MNG)
Beyond the preview
Go deeper on 2005-001078-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001078-29.